The list includes most sphingolipidoses (ASAH1, GBA, GLB1, HEXA, HEXB, GM2A, PSAP, SMPD1), MPS (IDUA, SGSH, NAGLU, HGSNAT, GNS, ARSB, GUSB) and mucolipidoses (GNPTAB, GNPTG), as well as glycoproteinoses (MAN2B1, FUCA1, NEU1, CTSA), lipid storage diseases (LIPA), post‐translational modification defects (SUMF1), and lysosomal integral protein disorders (LAMP2, NPC1, NPC2, SCARB2, SLC17A5). Here, CTSA is linked to Lipid storage disease.